No Association between Age of Transfused Red Cells and 30-Day Mortality in Massively Transfused Patients: Results from the Australian and New Zealand Massive Transfusion Registry

Nicholas H. Saadah, Erica Wood, Micahel J. Bailey, D. James Cooper, Craig French, Zoe McQuilten

Research output: Contribution to journalMeeting Abstractpeer-review


Clinical trials studying age of transfused red blood cells (RBCs) have found no evidence of benefit from transfusion of fresher RBCs. However, these studies have not included patients requiring massive transfusion for major bleeding, a patient population that may be more susceptible to adverse effects of the RBC storage lesion. Further, no clinical trials have specifically evaluated the safety of transfusing RBCs approaching expiry (30-42 days). We investigated the association between RBC storage time and 30-day mortality in a large cohort of massively transfused patients (5 RBCs within 4 hours, from any bleeding context).
Original languageEnglish
Article number3728
Number of pages1
Issue numberSuppl 1
Publication statusPublished - 2017


  • Blood
  • Red cells
  • red cell transfusion
  • intensive care

Cite this